PPIDT00300

Drug Information
NameEftrenonacog alfa
SequenceNot Available
DrugBank_IDDB11608
Typebiotech
IndicationIndicated for the treatment and prophylaxis of bleeding in patients of all age with haemophilia B (congenital factor IX deficiency).

Dosage Forms
Form Route Strength
Injection, powder, for solution Intravenous
1000 IU
Injection, powder, for solution Intravenous
2000 IU
Injection, powder, for solution Intravenous
250 IU
Injection, powder, for solution Intravenous
3000 IU
Injection, powder, for solution Intravenous
500 IU
Kit Intravenous
1000 [iU]/5mL
Kit Intravenous
2000 [iU]/5mL
Kit Intravenous
250 [iU]/5mL
Kit Intravenous
3000 [iU]/5mL
Kit Intravenous
4000 [iU]/5mL
Kit Intravenous
500 [iU]/5mL
Kit; powder, for solution Intravenous
1000 [iU]/5mL
Kit; powder, for solution Intravenous
1000 unit / vial
Kit; powder, for solution Intravenous
2000 unit / vial
Kit; powder, for solution Intravenous
2000 [iU]/5mL
Kit; powder, for solution Intravenous
250 unit / vial
Kit; powder, for solution Intravenous
250 [iU]/5mL
Kit; powder, for solution Intravenous
3000 [iU]/5mL
Kit; powder, for solution Intravenous
3000 unit / vial
Kit; powder, for solution Intravenous
4000 [iU]/5mL
Kit; powder, for solution Intravenous
4000 unit / vial
Kit; powder, for solution Intravenous
500 unit / vial
Kit; powder, for solution Intravenous
500 [iU]/5mL
Injection, powder, lyophilized, for solution Intravenous
25000000 IU
Target Information
Role Uniprot_ID Gene_Name Entity_Name Organism Actions Internal link
target P55899 FCGRT IgG receptor FcRn large subunit p51 Homo sapiens ligand Link